Illudin

From WikiMD's WELLNESSPEDIA

File:Illudin family.svg
Diagram of the Illudin family of compounds

Illudin refers to a group of natural sesquiterpenes that are primarily found in certain species of mushrooms, notably those belonging to the genus Omphalotus. These compounds are known for their toxic properties and have been studied for their potential use in cancer treatment due to their ability to induce apoptosis in cancer cells.

Chemical Structure[edit]

Illudins are characterized by their unique chemical structure, which includes a bicyclic framework. The most well-known members of this family are illudin S and illudin M. These compounds are structurally related to other sesquiterpenes but are distinguished by their reactive epoxide group, which is believed to be responsible for their biological activity.

Biological Activity[edit]

Illudins exhibit potent cytotoxic effects, which have been attributed to their ability to alkylate DNA. This property makes them of interest in the development of chemotherapy agents. However, their high toxicity also poses significant challenges in therapeutic applications.

Medical Research[edit]

Research into illudins has focused on modifying their structure to reduce toxicity while retaining anticancer activity. One such derivative, irofulven, has shown promise in clinical trials. Irofulven is a semisynthetic analog of illudin S and has been studied for its effectiveness against various types of cancer, including prostate cancer and ovarian cancer.

Toxicity[edit]

The toxicity of illudins is a major concern, as ingestion of mushrooms containing these compounds can lead to severe gastrointestinal distress and liver damage. The mechanism of toxicity is thought to involve the formation of DNA adducts, leading to cell death.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.